Volumetric absorptive microsampling as an effective microsampling technique for LC–MS/MS bioanalysis of biomarkers in drug discovery
Abstract
Aim: Develop and validate a volumetric absorptive microsampling (VAMS)-based LC–MS/MS method to support the bioanalysis of amino acid and carboxylic acid biomarkers in mouse whole blood. Method: Mouse whole blood was collected using a 10 μl VAMS device. The analytes in VAMS were extracted and analyzed using an LC–MS/MS method. Results: The VAMS-based LC–MS/MS assay exhibited a linearity range of 10.0–10,000 ng/ml with acceptable precision and accuracy and consistent recovery. The analyte stability in mouse whole blood VAMS was shown for 7 days at ambient conditions and at -80°C, as well as with three freeze/thaw cycles. Conclusion: A simple and robust VAMS-based LC–MS/MS method was developed and further validated for simultaneous bioanalysis of nine biomarkers in mouse whole blood.
Papers of special note have been highlighted as: • of interest; •• of considerable interest
References
- 1. . Volumetric absorptive microsampling: a dried sample collection technique for quantitative bioanalysis. Anal. Chem. 86, 8489–8495 (2014). • A quantitative bioanalytical approach using volumetric absorptive microsampling is highlighted.
- 2. . Dried blood spot for global health diagnostics and surveillance: opportunities and challenges. Am. J. Trop. Med. Hyg. 99(2), 256–265 (2018). • In quantitative bioanalysis, the advantages and challenges of dried blood spot microsampling are discussed.
- 3. Extractability-mediated stability bias and hematocrit impact: high extraction recovery is critical to feasibility of volumetric adsorptive microsampling (VAMS) in regulated bioanalysis. J. Pharm. Biomed. Anal. 156, 58–66 (2018). •• How to utilize volumetric absorptive microsampling for regulated bioanalysis and how to achieve high extraction recovery from samples collected using volumetric absorptive microsampling tips are discussed.
- 4. Neonatal and carrier screening for rare diseases: how innovation challenges screening criteria worldwide. J. Community Genet. 12(2), 257–265 (2021).
- 5. Implementing dried blood spot sampling for clinical pharmacokinetic determinations: considerations from the IQ consortium microsampling working group. AAPS J. 17, 292–300 (2015).
- 6. Use of dried blood spot samples for SARS-CoV-2 antibody detection using the Roche Elecsys® high throughput immunoassay. J. Clin. Virol. 136, 1–7 (2021).
- 7. Microsampling: considerations for its use in pharmaceutical drug discovery and development. Bioanalysis 11(10), 1015–1038 (2019).
- 8. Capillary microsampling of mouse blood in early pre-clinical studies: a preferred alternative to dried blood spot sampling. J. Bioanal. Biomed. 2(8), 28–33 (2016). •• Drug discovery benefits from using volumetric absorptive microsampling over dried blood spot are discussed.
- 9. . A review of microsampling techniques and their social impact. Biomed. Microdevices 21(81), 1–30 (2019).
- 10. Application of volumetric absorptive microsampling for robust, high-throughput mass spectrometric quantification of circulating protein biomarkers. Clin. Mass Spectrom. 4-5, 25–33 (2017).
- 11. . Dried blood microsample-assisted determination of vitamins: recent developments and challenges. TrAC 132, 1–9 (2020).
- 12. Application of volumetric absorptive microsampling (VAMS) to measure multidimensional anti-influenza IgG antibodies by the mPlex-Flu assay. J. Clin. Transl. Sci. 3, 332–343 (2019).
- 13. A good practice guide to the administration of substances and removal of blood, including routes and volumes. J. Appl. Toxicol. 21, 15–23 (2001).
- 14. . Organic acidurias: an updated review. Indian J. Clin. Biochem. 26, 319–325 (2011).
- 15. Guidance for Industry Bioanalytical Method Validation. US FDA, Rockville, MD, USA (2018). •• Guidelines for validating bioanalytical method.
- 16. . Tutorial: volumetric absorptive microsampling (VAMS). Anal. Chim. Acta 1046, 32–47 (2019).